241 related articles for article (PubMed ID: 28057023)
1. XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell.
Huang C; Zeng X; Jiang G; Liao X; Liu C; Li J; Jin H; Zhu J; Sun H; Wu XR; Huang C
J Hematol Oncol; 2017 Jan; 10(1):6. PubMed ID: 28057023
[TBL] [Abstract][Full Text] [Related]
2. X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis.
Cao Z; Zhang R; Li J; Huang H; Zhang D; Zhang J; Gao J; Chen J; Huang C
J Biol Chem; 2013 Jul; 288(28):20238-47. PubMed ID: 23720779
[TBL] [Abstract][Full Text] [Related]
3. The RING domain in the anti-apoptotic protein XIAP stabilizes c-Myc protein and preserves anchorage-independent growth of bladder cancer cells.
Jiang G; Huang C; Liao X; Li J; Wu XR; Zeng F; Huang C
J Biol Chem; 2019 Apr; 294(15):5935-5944. PubMed ID: 30819803
[TBL] [Abstract][Full Text] [Related]
4. XIAP RING domain mediates miR-4295 expression and subsequently inhibiting p63α protein translation and promoting transformation of bladder epithelial cells.
Jin H; Xu J; Guo X; Huang H; Li J; Peng M; Zhu J; Tian Z; Wu XR; Tang MS; Huang C
Oncotarget; 2016 Aug; 7(35):56540-56557. PubMed ID: 27447744
[TBL] [Abstract][Full Text] [Related]
5. X-linked inhibitor of apoptosis protein (XIAP) lacking RING domain localizes to the nuclear and promotes cancer cell anchorage-independent growth by targeting the E2F1/Cyclin E axis.
Cao Z; Li X; Li J; Luo W; Huang C; Chen J
Oncotarget; 2014 Aug; 5(16):7126-37. PubMed ID: 25216527
[TBL] [Abstract][Full Text] [Related]
6. A new tumour suppression mechanism by p27Kip1: EGFR down-regulation mediated by JNK/c-Jun pathway inhibition.
Fang Y; Wang Y; Wang Y; Meng Y; Zhu J; Jin H; Li J; Zhang D; Yu Y; Wu XR; Huang C
Biochem J; 2014 Nov; 463(3):383-92. PubMed ID: 25121353
[TBL] [Abstract][Full Text] [Related]
7. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
[TBL] [Abstract][Full Text] [Related]
8. A single BIR domain of XIAP sufficient for inhibiting caspases.
Takahashi R; Deveraux Q; Tamm I; Welsh K; Assa-Munt N; Salvesen GS; Reed JC
J Biol Chem; 1998 Apr; 273(14):7787-90. PubMed ID: 9525868
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-200c stabilizes XIAP mRNA and contributes to invasion and lung metastasis of bladder cancer.
Jin H; Xue L; Mo L; Zhang D; Guo X; Xu J; Li J; Peng M; Zhao X; Zhong M; Xu D; Wu XR; Huang H; Huang C
Cell Adh Migr; 2019 Dec; 13(1):236-248. PubMed ID: 31240993
[TBL] [Abstract][Full Text] [Related]
10. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
11. Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.
Shrader M; Pino MS; Lashinger L; Bar-Eli M; Adam L; Dinney CP; McConkey DJ
Cancer Res; 2007 Feb; 67(4):1430-5. PubMed ID: 17308080
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
Zhang Y; Talmon G; Wang J
Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed miR-200a promotes bladder cancer invasion through direct regulating Dicer/miR-16/JNK2/MMP-2 axis.
Yang R; Xu J; Hua X; Tian Z; Xie Q; Li J; Jiang G; Cohen M; Sun H; Huang C
Oncogene; 2020 Feb; 39(9):1983-1996. PubMed ID: 31772330
[TBL] [Abstract][Full Text] [Related]
14. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
Cui W; Zhang S; Shan C; Zhou L; Zhou Z
FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting apoptosis in mammalian cell culture using the caspase inhibitor XIAP and deletion mutants.
Sauerwald TM; Betenbaugh MJ; Oyler GA
Biotechnol Bioeng; 2002 Mar; 77(6):704-16. PubMed ID: 11807766
[TBL] [Abstract][Full Text] [Related]
16. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.
Adam L; Zhong M; Choi W; Qi W; Nicoloso M; Arora A; Calin G; Wang H; Siefker-Radtke A; McConkey D; Bar-Eli M; Dinney C
Clin Cancer Res; 2009 Aug; 15(16):5060-72. PubMed ID: 19671845
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192/XIAP axis.
Li H; He L; Tuo Y; Huang Y; Qian B
BMC Cancer; 2020 Oct; 20(1):1026. PubMed ID: 33097010
[TBL] [Abstract][Full Text] [Related]
18. XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIβ mRNA stability.
Yu Y; Jin H; Xu J; Gu J; Li X; Xie Q; Huang H; Li J; Tian Z; Jiang G; Chen C; He F; Wu XR; Huang C
Int J Cancer; 2018 May; 142(10):2040-2055. PubMed ID: 29250796
[TBL] [Abstract][Full Text] [Related]
19. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
[TBL] [Abstract][Full Text] [Related]
20. E3 ligase activity of XIAP RING domain is required for XIAP-mediated cancer cell migration, but not for its RhoGDI binding activity.
Liu J; Zhang D; Luo W; Yu J; Li J; Yu Y; Zhang X; Chen J; Wu XR; Huang C
PLoS One; 2012; 7(4):e35682. PubMed ID: 22532870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
